Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients-Reference-Cited by-同舟云学术

Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients

Published:2014 Issue:5 Volume:5 Page:390-397
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Sato Yumiko,Kondo Masahiro,Inagaki Atsushi,Komatsu Hirokazu,Okada Chika,Naruse Kumi,Sahashi Tomoyo,Kuroda Junko,Ogura Hiroka,Uegaki Shiori,Yoshida Tatsuya,Mori Yoshinori,Sawada Hiroo,Watanabe Shoichi,Sugiura Hiroshi,Endo Yumi,Yoshimoto Nobuyasu,Toyama Tatsuya,Iida Shinsuke,Yamada Koichi,Kimura Kazunori,Wakita Atsushi

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the Efficacy of Fosnetupitant, an NK<sub>1</sub> Receptor Antagonist in CDDP-Based Regimens, with That of Fosaprepitant and Aprepitant: A Retrospective Observational Study;Biological and Pharmaceutical Bulletin;2024-03-25

2. Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective;Advances in Therapy;2023-03-08

3. Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex;Drug Delivery;2023-02-27

4. Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells;Oncology Letters;2022-09-16

5. A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients;Supportive Care in Cancer;2022-05-02